Related Experiment Video
Updated: Apr 24, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression
Shi-Jun Tong1, Jun Liu1, Xiang Wang1
1Department of Urologic Surgery, Huashan Hospital Affiliated to Fudan University, Shanghai 200040, P.R. China.
Abstract:
microRNAs (miRNAs) are a class of short noncoding RNA molecules that have a critical role in the initiation and progression of types of human cancer, including prostate cancer. In the present study, the expression of miR-181 in prostate cancer tissues was evaluated and was demonstrated to be significantly upregulated in prostate cancer tissues compared with that in adjacent normal tissues. The results of in vitro MTT and BrdU incorporation assays, as well as cell-cycle analysis, indicated that miR-181 overexpression markedly promoted the proliferation of LNCaP cells. Furthermore, miR-181 overexpression was found to promote the progression of LNCaP tumor growth in nude mice. Mechanistic studies demonstrated that dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, gene 1 (DAX-1), a negative regulator of androgen receptor in prostate cancer, was inhibited by miR-181 overexpression. Therefore, the results from the present study suggest that miR-181 functions as a growth-suppressive miRNA during prostate cancer development.
Insights
MicroRNAs (miRNAs) like miR-181 are implicated in prostate cancer. This study found miR-181 promotes cancer cell proliferation and tumor growth by inhibiting DAX-1, suggesting it acts as a growth-suppressive miRNA.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) are key regulators in human cancer development, including prostate cancer.
- Understanding specific miRNA roles is crucial for targeted cancer therapies.
Purpose of the Study:
- To investigate the role of miR-181 in prostate cancer.
- To determine the effect of miR-181 on prostate cancer cell proliferation and tumor growth.
- To elucidate the underlying molecular mechanism of miR-181 action.
Main Methods:
- Quantitative analysis of miR-181 expression in prostate cancer tissues versus normal tissues.
- In vitro assays (MTT, BrdU incorporation, cell-cycle analysis) to assess proliferation effects of miR-181 overexpression in LNCaP cells.
- In vivo studies using nude mice to evaluate the impact of miR-181 on tumor growth.
- Mechanistic studies to identify miR-181 targets, specifically focusing on DAX-1.
Main Results:
- miR-181 was significantly upregulated in prostate cancer tissues compared to adjacent normal tissues.
- Overexpression of miR-181 markedly promoted proliferation of LNCaP cells in vitro.
- miR-181 overexpression enhanced LNCaP tumor growth progression in vivo.
- Mechanistic studies revealed that miR-181 inhibits DAX-1, a negative regulator of the androgen receptor in prostate cancer.
Conclusions:
- miR-181 plays a significant role in promoting prostate cancer cell proliferation and tumor growth.
- The inhibitory effect of miR-181 on DAX-1 is a key mechanism driving its oncogenic function.
- These findings suggest miR-181 acts as a growth-suppressive miRNA in prostate cancer development, despite its observed upregulation and pro-proliferative effects.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Ras Gene
Ras is a...
Canonical Wnt Signaling Pathway

